New Approach to the Diagnosis and Treatment of NAFLD
Kenneth Cusi, MD, FACP, FACE, discusses Treating Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes. He examines how fatty liver impacts the care of every patient with obesity, Type 2 Diabetes and cardiovascular disease. He shares how to identify and incorporate into patient care, the latest information into the diagnosis and treatment of nonalcoholic fatty liver disease, and the latest advancements in medicational developments coming in 2020.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.